FDA halts cancer trial after 3 patient deaths

Following two patient deaths last week and another earlier this year, Juno Therapeutics announced Thursday that it is putting its "ROCKET" trial on clinical hold, at the direction of the U.S. Food and Drug Administration.
Source: WDSU.com - Health - Category: Consumer Health News Source Type: news